Grant Verstandig - 31 May 2022 Form 4 Insider Report for NexImmune, Inc.

Role
Director
Signature
/s/ Andrew Pearce, Attorney-in-fact
Issuer symbol
NEXI on OTC
Transactions as of
31 May 2022
Net transactions value
+$297,561
Form type
4
Filing time
02 Jun 2022, 19:42:10 UTC
Previous filing
28 Mar 2022
Next filing
07 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NEXI Common Stock Purchase $106,683 +47,900 +4.8% $2.23* 1,038,619 02 Jun 2022 Direct F1, F2
transaction NEXI Common Stock Purchase $95,760 +40,200 +4.2% $2.38* 990,719 01 Jun 2022 Direct F2, F3
transaction NEXI Common Stock Purchase $95,118 +45,024 +5% $2.11* 950,519 31 May 2022 Direct F2, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.09 to $2.38, inclusive. The reporting person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price.
F2 Excludes 17,376 shares of common stock underlying options that are currently exercisable.
F3 The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.20 to $2.50, inclusive. The reporting person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price.
F4 The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.03 to $2.46, inclusive. The reporting person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price.